Concepedia
Cancer · 2000 · 34 citations · 13 references
Open access
The combination of vinorelbine and estramustine is a well-tolerated and modestly active regimen in men with androgen-independent metastatic prostate cancer.
13
What is the maximum number of levels needed in pain intensity measurement?
Mark P. Jensen, Judith A. Turner, Joan M. Romano · Pain · 1994 · 596 citations
Pain Therapy, Pain Intensity Measurement, Acute Pain +16
Phase I Trial of Docetaxel With Estramustine in Androgen-Independent Prostate Cancer
Daniel P. Petrylak, Robert B. MacArthur, John F. O’Connor et al. · Journal of Clinical Oncology · 1999 · 312 citations
Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer.
G. R. Hudes, Faith E. Nathan, Carine Khater et al. · Journal of Clinical Oncology · 1997 · 273 citations
Vinblastine Versus Vinblastine Plus Oral Estramustine Phosphate for Patients With Hormone-Refractory Prostate Cancer: A Hoosier Oncology Group and Fox Chase Network Phase III Trial
Gary R. Hudes, Lawrence H. Einhorn, Eric A. Ross et al. · Journal of Clinical Oncology · 1999 · 204 citations
Phase II Trial of Oral Estramustine, Oral Etoposide, and Intravenous Paclitaxel in Hormone-Refractory Prostate Cancer
David C. Smith, Peg Esper, Myla Strawderman et al. · Journal of Clinical Oncology · 1999 · 160 citations